Pages that link to "Q37300942"

The following pages link to Recent developments in the treatment of renal cell carcinoma (Q37300942):

Displaying 29 items.

• Immunotherapy for metastatic renal cell carcinoma (Q24186688) (← links)
• The PI3K/AKT Pathway and Renal Cell Carcinoma (Q26800216) (← links)
• Immunotherapy for metastatic renal cell carcinoma (Q30234458) (← links)
• C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells (Q33681198) (← links)
• Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival (Q33898664) (← links)
• Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma (Q35043936) (← links)
• Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review (Q35167535) (← links)
• Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis. (Q35741048) (← links)
• The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study (Q35918881) (← links)
• miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression (Q36107781) (← links)
• Surgical challenges in the treatment of a giant renal cell carcinoma with atypical presentation: A case report (Q36918877) (← links)
• Transgenic expression of the N525S-tuberin variant in Tsc2 mutant (Eker) rats causes dominant embryonic lethality (Q37737055) (← links)
• The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease (Q38419495) (← links)
• RNA interference-mediated knockdown of astrocyte elevated gene-1 inhibits growth, induces apoptosis, and increases the chemosensitivity to 5-fluorouracil in renal cancer Caki-1 cells. (Q38937182) (← links)
• Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2. (Q39699164) (← links)
• Detecting functional changes with [(18)F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy (Q41505826) (← links)
• Antitumour and antiangiogenic activities of [Pt(O,O'-acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma. (Q41881241) (← links)
• HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma (Q42378360) (← links)
• Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma (Q46429988) (← links)
• Targeted Silencing of Kim-1 Inhibits the Growth of Clear Cell Renal Carcinoma Cell Line 786-0 In Vitro and In Vivo. (Q49361010) (← links)
• Immunohistochemical distinction of metastases of renal cell carcinoma with molecular analysis of overexpression of the chemokines CXCR2 and CXCR3 as independent positive prognostic factors for the tumorigenesis. (Q51714575) (← links)
• Sunitinib resistance in renal cell carcinoma. (Q51763292) (← links)
• Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5. (Q52586063) (← links)
• Quantification of sarcomatoid differentiation in renal cell carcinoma on magnetic resonance imaging. (Q55327529) (← links)
• Prognostic investigations of B7-H1 and B7-H4 expression levels as independent predictor markers of renal cell carcinoma (Q56486867) (← links)
• MiR-543 promotes cell proliferation and metastasis of renal cell carcinoma by targeting Dickkopf 1 through the Wnt/β-catenin signaling pathway (Q58555659) (← links)
• TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A (Q59883261) (← links)
• Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database (Q89507779) (← links)
• AURKB: a promising biomarker in clear cell renal cell carcinoma (Q90428162) (← links)